Adam Woodrow - Aug 8, 2023 Form 4 Insider Report for Paratek Pharmaceuticals, Inc. (PRTK)

Role
President & Chief Commercial
Signature
/s/ William M. Haskel, Attorney-in-Fact for Adam Woodrow
Stock symbol
PRTK
Transactions as of
Aug 8, 2023
Transactions value $
$0
Form type
4
Date filed
8/10/2023, 08:41 PM
Previous filing
Dec 22, 2022
Next filing
Sep 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRTK Common Stock Award $0 +98.8K +15.16% $0.00 750K Aug 8, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on March 30, 2021 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on August 8, 2023.